Full Text of PDF (64k)
Article in Japanese
Abstract
Case Report
A case of rheumatoid arthritis presenting with pulmonary tuberculosis
Kiyosi Katoh1) 2) 3) Hitomi Taniguchi1) Akiko Okouchi3) Makoto Kudo3) Takako Kawai3)
1)Department of Internal Medicine, Yokohama General Hospital, 2201 Kurogane-cho, Aoba-ku, Yokohama,
2)Department of Biomedical Engineering, Toin University of Yokohama,
3)Deparmtment of Internal Medicine, Yokohama Seamen's Insurance Hospital
ABSTRACT
A 72-year-old man who had been suffering from rheumatoid arthritis for 25 years developed pulmonary tuberculosis after treatment with infliximab. He had been receiving this treatment since December 2003. Forty-six days later, a fever developed and the patient was hospitalized on February 3, 2004. Chest radiography and chest CT showed an infiltrative shadow with cavity formation. Mycobacterium tuberculosis was detected in the sputum. Infliximab is a monoclonal antibody toward tumor necrosis factor alpha (TNFα ). It has been reported that infliximab increases the risk of tuberculosis in patients with rheumatoid arthritis in Europe and north America. This is the first case of pulmonary tuberculosis in a patient treated with infliximab in Japan.
KEYWORDS
Infliximab Rheumatoid arthritis Pulmonary tuberculosis
Received 平成16年2月25日
JJRS, 42(8): 782-786, 2004
Copyright © The Japanese Respiratory Society All Rights Reserved.